174 related articles for article (PubMed ID: 9689117)
1. Light chain-associated amyloid deposits comprised of a novel kappa constant domain.
Solomon A; Weiss DT; Murphy CL; Hrncic R; Wall JS; Schell M
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9547-51. PubMed ID: 9689117
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel substitution in the constant region of a gene coding for an amyloidogenic kappa1 light chain.
Wally J; Kica G; Zhang Y; Ericsson T; Connors LH; Benson MD; Liepnieks JJ; Murray J; Skinner M; Comenzo RL
Biochim Biophys Acta; 1999 May; 1454(1):49-56. PubMed ID: 10354514
[TBL] [Abstract][Full Text] [Related]
3. A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues.
Foss GS; Nilsen R; Cornwell GC; Husby G; Sletten K
Scand J Immunol; 1998 Apr; 47(4):348-54. PubMed ID: 9600316
[TBL] [Abstract][Full Text] [Related]
4. ALkappa(I) (UNK) - primary structure of an AL-amyloid protein presenting an organ-limited subcutaneous nodular amyloid syndrome of long duration. Case report and review.
Wiegel NM; Mentele R; Kellermann J; Meyer L; Riess H; Linke RP
Amyloid; 2010 Mar; 17(1):10-23. PubMed ID: 20146644
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin heavy-chain-associated amyloidosis.
Eulitz M; Weiss DT; Solomon A
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6542-6. PubMed ID: 2118650
[TBL] [Abstract][Full Text] [Related]
6. Tertiary structure of an amyloid immunoglobulin light chain protein: a proposed model for amyloid fibril formation.
Schormann N; Murrell JR; Liepnieks JJ; Benson MD
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9490-4. PubMed ID: 7568160
[TBL] [Abstract][Full Text] [Related]
7. Bence Jones proteins and light chains of immunoglobulins. XIII. Effect of elastase-like and chymotrypsin-like neutral proteases derived from human granulocytes on Bence Jones proteins.
Solomon A; Schmidt W; Havemann K
J Immunol; 1976 Sep; 117(3):1010-4. PubMed ID: 60445
[TBL] [Abstract][Full Text] [Related]
8. Shoulder-pad sign of amyloidosis: structure of an Ig kappa III protein.
Liepnieks JJ; Burt C; Benson MD
Scand J Immunol; 2001 Oct; 54(4):404-8. PubMed ID: 11555407
[TBL] [Abstract][Full Text] [Related]
9. Structural analysis of the amyloidogenic kappa Bence Jones protein (FUR).
Odani S; Komori Y; Gejyo F
Amyloid; 1999 Jun; 6(2):77-88. PubMed ID: 10439113
[TBL] [Abstract][Full Text] [Related]
10. Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins.
Stevens PW; Raffen R; Hanson DK; Deng YL; Berrios-Hammond M; Westholm FA; Murphy C; Eulitz M; Wetzel R; Solomon A
Protein Sci; 1995 Mar; 4(3):421-32. PubMed ID: 7795526
[TBL] [Abstract][Full Text] [Related]
11. Decreased amyloidogenicity caused by mutational modulation of surface properties of the immunoglobulin light chain BRE variable domain.
Kobayashi Y; Tsutsumi H; Abe T; Ikeda K; Tashiro Y; Unzai S; Kamikubo H; Kataoka M; Hiroaki H; Hamada D
Biochemistry; 2014 Aug; 53(31):5162-73. PubMed ID: 25062800
[TBL] [Abstract][Full Text] [Related]
12. Primary amyloidosis associated with a novel heavy-chain fragment (AH amyloidosis).
Solomon A; Weiss DT; Murphy C
Am J Hematol; 1994 Feb; 45(2):171-6. PubMed ID: 8141123
[TBL] [Abstract][Full Text] [Related]
13. Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein.
Engvig JP; Olsen KE; Gislefoss RE; Sletten K; Wahlström O; Westermark P
Scand J Immunol; 1998 Jul; 48(1):92-8. PubMed ID: 9714416
[TBL] [Abstract][Full Text] [Related]
14. Structural relationship of kappa-type light chains with AL amyloidosis: multiple deletions found in a VkappaIV protein.
Alim MA; Yamaki S; Hossain MS; Takeda K; Kozima M; Izumi T; Takashi I; Shinoda T
Clin Exp Immunol; 1999 Dec; 118(3):344-8. PubMed ID: 10594550
[TBL] [Abstract][Full Text] [Related]
15. Localized amyloidosis of the larynx: evidence for light chain composition.
Berg AM; Troxler RF; Grillone G; Kasznica J; Kane K; Cohen AS; Skinner M
Ann Otol Rhinol Laryngol; 1993 Nov; 102(11):884-9. PubMed ID: 8239352
[TBL] [Abstract][Full Text] [Related]
16. Bence Jones proteins and light chains of immunoglobulins. XI. A transient Bence Jones-related protein associated with corticosteroid therapy.
Solomon A; McLaughlin CL; Capra JD
J Clin Invest; 1975 Mar; 55(3):579-86. PubMed ID: 803979
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin kappa light chain and its amyloidogenic mutants: a molecular dynamics study.
Nowak M
Proteins; 2004 Apr; 55(1):11-21. PubMed ID: 14997536
[TBL] [Abstract][Full Text] [Related]
18. Primary structure of the variable part of an amyloidogenic Bence-Jones Protein (Mev.). An unusual insertion in the third hypervariable region of a human kappa-immunoglobulin light chain.
Eulitz M; Linke RP
Hoppe Seylers Z Physiol Chem; 1982 Nov; 363(11):1347-58. PubMed ID: 6816713
[TBL] [Abstract][Full Text] [Related]
19. The V kappa III subgroup light chain proteins in AL amyloidosis & autoimmune diseases.
Alim MA; Hara Y; Kaji H; Shinoda T
Indian J Med Res; 2001 Jul; 114():30-5. PubMed ID: 11762204
[TBL] [Abstract][Full Text] [Related]
20. Differential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycans.
Blancas-Mejía LM; Hammernik J; Marin-Argany M; Ramirez-Alvarado M
J Biol Chem; 2015 Feb; 290(8):4953-4965. PubMed ID: 25538238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
